Rainmed Medical Limited

As of December 31, 2024, Rainmed Medical Limited carries a market capitalization of 199.69M, placing it among publicly traded companies globally. Its enterprise value stands at 11.27M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Rainmed Medical Limited has 1.17B shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Rainmed Medical Limited maintains a current ratio of 4.92, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 23, 2026, Rainmed Medical Limited's stock has declined approximately 49.00% over the past 52 weeks. The 50-day moving average sits at 0.17, while the 200-day moving average is 0.24.

As of December 31, 2024, Rainmed Medical Limited holds 218.75M in cash and equivalents against 27.22M in total debt, resulting in a net debt position of -34.09M. Total book value stands at 433.13M, with working capital of 201.75M providing operational flexibility.